SCHEMBL9217552

SCHEMBL9217552

COC(=O)CN(C)C(=O)Cc1cccc([N+](=O)[O-])c1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.60
OPRK1 P41145 1/20 0.51
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
MAOB P27338 2/20 0.48
MAOA P21397 1/20 0.48
IDO1 P14902 1/20 0.47
ACHE P22303 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
ALDH1A1 P00352 2/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
RECQL P46063 1/20 0.46
TSHR P16473 1/20 0.46
HTT P42858 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
PYCR1 P32322 1/20 0.45
RAB9A P51151 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL520733 0.83 MEN1 (0.58) MEN1KMT2AMAOBMAOASMN1; SMN2
SCHEMBL15272040 0.82 SIGMAR1 (0.62) SIGMAR1OPRK1MAOBMAOAACHE
SCHEMBL27546572 0.82 PYCR1 (0.60) MEN1KMT2AMAOBMAOAACHE
SCHEMBL4446274 0.81 SIGMAR1 (0.58) SIGMAR1OPRK1MAOBMAOAACHE
SCHEMBL10533234 0.81 CYP2D6 (0.62) MEN1KMT2AMAOBMAOAACHE
SCHEMBL30537979 0.81 SIGMAR1 (0.58) SIGMAR1OPRK1MAOBMAOAACHE
SCHEMBL12310918 0.81 ALDH1A1 (0.52) MEN1KMT2ASMN1; SMN2ALDH1A1TSHR
SCHEMBL2111020 0.77 KMT2A (0.65) SIGMAR1MEN1KMT2AMAOBMAOA
SCHEMBL7640869 0.76 TSHR (0.54) SIGMAR1MEN1KMT2AMAOBMAOA
SCHEMBL5461014 0.76 SIGMAR1 (0.56) SIGMAR1OPRK1SMN1; SMN2ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0549039-B1 3-Phenylureido-1,4-Benzodiazepinones and their use as cholecystokinin or gastrin antagonists MERCK SHARP & DOHME (GB) 1995-08-09 EP disclosed
US-5410049-A Gastrin and cholecystokinin inhibitor MERCK SHARPE & DOHME LTD. (GB) 1995-04-25 US disclosed
EP-0549039-A1 3-Phenylureido-1,4-Benzodiazepinones and their use as cholecystokinin or gastrin antagonists MERCK SHARP & DOHME LTD. (GB) 1993-06-30 EP disclosed